1. Home
  2. Analysis
  3. Emgality
  4. Invokana

Emgality and Invokana drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Emgality and Invokana. Common interactions include arthralgia among females.

The phase IV clinical study analyzes what interactions people who take Emgality and Invokana have. It is created by eHealthMe based on reports of 8 people who take Emgality and Invokana from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 30, 2022

8 people who take Emgality and Invokana together, and have interactions are studied.

What is Emgality?

Emgality has active ingredients of galcanezumab-gnlm. eHealthMe is studying from 18,845 Emgality users for its effectiveness, alternative drugs and more.

What is Invokana?

Invokana has active ingredients of canagliflozin. It is often used in diabetes. eHealthMe is studying from 28,852 Invokana users for its effectiveness, alternative drugs and more.

Number of Emgality and Invokana reports submitted per year:

Emgality and Invokana drug interactions.

Common Emgality and Invokana drug interactions by gender *:

female:

  1. Arthralgia
  2. Alopecia
  3. Pain in extremity
  4. Panic attack
  5. Sciatica
  6. Asthma
  7. Blood glucose increased
  8. Breast cancer
  9. Drug ineffective
  10. Feeling jittery

male:

n/a

Common Emgality and Invokana drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Panic attack
  2. Blood glucose increased
  3. Feeling jittery

40-49:

  1. Arthralgia
  2. Gait disturbance
  3. Hypoaesthesia
  4. Pain in extremity
  5. Sciatica

50-59:

n/a

60+:

  1. Alopecia
  2. Drug ineffective
  3. Migraine

* Approximation only. Some reports may have incomplete information.

Do you take Emgality and Invokana?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Emgality and Invokana:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Emgality side effects:

Browse all side effects of Emgality:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Invokana side effects:

Browse all side effects of Invokana:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Emgality interactions:

Browse all interactions between Emgality and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Invokana interactions:

Browse all interactions between Invokana and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on galcanezumab-gnlm and canagliflozin (the active ingredients of Emgality and Invokana, respectively), and Emgality and Invokana (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Emgality and Invokana.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.